Immunovant develops treatments that target the immune system to help people living with autoimmune diseases. Their main product is a laboratory-made antibody designed to treat conditions like Graves' disease and rheumatoid arthritis. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
